MYCN and neuroblastoma: We first confirmed that 1 mm of DFMO treatment significantly increased the uptake of radiolabeled putrescine and spermidine in both non‐MYCN amplified and MYCN‐amplified neuroblastoma cells (Fig. 3C,D).